Leucocyte-endothelial cell adhesion is modulated by a variety of adhesion glycoproteins expressed on the surface ofleucocytes and endothelial cells. Although in vitro studies show that these adhesion molecules mediate the decrease in leucocyte rolling velocity and the increase in leucocyte adherence and emigration associated with inflammation, there are few in vivo data to support this hypothesis. The aim of this study was to assess the role of leucocyte (CD11b/CD18) and endothelial cell (P-and E-selectin) 
The accumulation of leucocytes in inflamed tissue is preceded by leucocyte adhesion to vascular endothelium. This rate limiting step in the inflammatory response is modulated by a variety of adhesion glycoproteins expressed on the surface of leucocytes and endothelial cells. Recent in vitro studies show that different adhesion molecules participate in the low affinity binding that is manifested as leucocyte rolling and the high affinity binding associated with firm adhesion of leucocytes. P-and E-selectin are calcium dependent endothelial cell surface lectins that mediate leucocyte adhesion by recognition of cell specific carbohydrate ligands. P-selectin, which is stored in the Weibel-Palade bodies' interacts with the oligosaccharide sialyl Lewis x,2 3 and is proposed to mediate leucocyte rolling. 4 The expression of P-selectin at the cell surface resulting from exposure to histamine, hydrogen peroxide, and thrombin occurs quickly, but is short lived and declines within minutes.5 6 The cytokine inducible expression of E-selectin peaks in four to six hours, declines to basal values by hours, and requires de novo RNA and protein synthesis.7 The selectins bind to sialyl Lewis x and Lewis a oligosaccharides on the leucocyte surface8 9 and seem to be required for leucocyte rolling and transendothelial migration.10 Leucocyte adherence seems to be mediated by the CD1 lb/CD 18 adhesion glycoprotein complex on leucocytes, which interacts with its ligand, intercellular adhesion molecule-i (ICAM-1), on endothelial cells." The binding of CD 1 lb/ CD1 8 to ICAM-1 is essential for neutrophil emigration as shown in in vitro transmigration assays."1 12 Recent in vivo studies show that monoclonal antibodies (MAbs) against leucocyte (CD11/CD18) and endothelial cell (E-selectin, ICAM-1) adhesion molecules attenuate the recruitment of rolling, adherent, and emigrating leucocytes elicited by acute exposure of the mesenteric microcirculation to either leuketriene B4, platelet activating factor or low venular shear rates, while an anti-Pselectin MAb attenuates the rolling responses elicited by either platelet activating factor or low shear rates.'3 14 In addition, these MAbs significantly reduce the leucocyte adhesion and albumin leakage responses induced by acute exposure of the microcirculation to L-NAME, an inhibitor of nitric oxide synthesis. 15 While the aforementioned studies have provided much insight regarding the contribution of different adhesion molecules to the leucocyte-endothelial cell interactions associated with different acute (within minutes) inflammatory reactions, it remains unclear whether these adhesion molecules are equally important in modulating the leucocyte sequestration seen in tissues inflamed for days or weeks. Thus, the main objective of this study was to determine the contribution of The control group received two subcutaneous injections of the indomethacin vehicle, 5% NaHCO3, while group 1 received the indomethacin. When arterial pressure and erythrocyte velocity were stabile during superfusion with BBS, images from the mesenteric preparations -about 10 venules per animal -were videotaped for five minutes. The number of venules (and rats) evaluated in the control group and in groups 1, 2, 3, and 4 were 52 (5), 69 (7), 61 (6), 58 (6) , and 60 (6), respectively.
Tissue analysis After intravital microscopy the animals were killed with an overdose of pentobarbital and the intestines were excised and opened longitudinally. Gross findings were ranked using the following criteria: 0 -no change in serosa or mucosa, 1 -hyperaemic lesions or petechial bleeding, or both, 2 -single mucosal erosion or ulceration, 3 -multiple erosions or ulcerations without any lesions in the serosa and mesentery, or single mucosal erosion or ulcer with hyperaemic, adhesive or haemorrhagic lesions in the serosa, 4 -multiple erosions or ulcerations (less than 10 cm) with hyperaemic, adhesive or haemorrhagic lesions in the serosa, 5 -multiple erosions or ulcerations ( Figure 1 summarises the effects of the various MAbs on the indomethacin induced increase in leucocyte adherence in rat mesenteric venules compared with untreated rats. Two subcutaneous injections of indomethacin elicited a nearly eightfold increase in adherence (24.0 (1-6) v 3-1 (0-6) leucocytes per 100 ,um venule in control). While the anti-P-selectin antibody had no effect (24-2 (1.5)), the anti-Eselectin (14-2 (1 -1)) and anti-CD11b (5.2 (0.4)) MAbs significantly reduced the number of adherent leucocytes.
The sixfold increase in leucocyte emigration (Fig 2) resulting from indomethacin injections (14.5 (1.0) v 2.2 (0-6) leucocytes per field in control) was significantly blunted by anti-Pselectin (8-7 (0-6)), anti-E-selectin (7-9 (0-9)), and anti-CD 1 lb (4-2 (0.6)) MAbs. Effects of indomethacin and the MAbs to P-selectin, E-selectin, and CDI Ib/CD18 on mucosal ulceration and tissue myeloperoxidase activity The leucocyte rolling velocity (Fig 3) was reduced by 77% in response to indomethacin treatment (17.6 (1.2) v 76.2 (5.0) pfm/s in control). While the anti-E-selectin antibody had no effect on this response to indomethacin (19- 5 (1 1)) , the groups treated with either the anti-P-selectin (26'1 (2'1) ) or anti-CD1 lb (24.5 (2.8)) MIAbs showed a small but significant increase in rolling velocity, compared with indomethacin treatment alone.
The venular wall shear rate (Fig 4) was not affected by any of the treatments (control 432 (27) s-1, indomethacin 441 (29), anti-Pselectin 394 (25) , anti-CD11b 386 (29)) except the anti-E-selectin (525 (32)) antibody, which resulted in a slight increase compared with either control or indomethacin treated groups.
The indomethacin induced increase of leucocyte adhesion in mesenteric venules was accompanied by macroscopic mucosal ulcerations of the small bowel (ulcer index 4.0 (06) v 0 in control) and an increase of myeloperoxidase activity (90 1 (13.0) U/g wet weight v 47-2 (4.0) in control), an index of granulocyte infiltration into the inflamed tissue. While the macroscopic extent of ulceration was not significantly reduced by antibody treatment all antibodies blunted the indomethacin induced increase in myeloperoxidase activity (Table) . Discussion Leucocyte-endothelial cell adhesion is a complex process involving several families of adhesion molecules, including the leucocyte specific 32-integrins (CD1 1/CD18), the endothelial cell associated immunoglobulins (ICAMs) , and the selectins. The relative importance of these adhesion molecules to the process of leucocyte adhesion (leucocyte rolling, adhesion, and emigration) has been largely assessed using isolated neutrophils and monolayers of cultured endothelial cells. There have been only a few reports that assess the importance of adhesion molecules in modulating leucocyte adhesion within the microcirculation. 13-15 25 In vivo studies show that leucocyte rolling in postcapillary venules is mediated by P-selectin on endothelial cells and L-selectin on the surface of leucocytes.25 26 In the report by Zimmerman and coworkersl4 the role of adhesion molecules in an acute (by superfusion of the venular preparation) leukotriene B4 and platelet activating factor induced increase in leucocyte-endothelial cell adhesion was examined in rat mesenteric venules. While
MAbs against CD1 ib, CD 18, ICAM-1, and E-selectin significantly reduced leucocyte adherence and emigration elicited by both lipid inflammatory mediators, the MAb against P-selectin reduced neutrophil rolling only under conditions of platelet activating factor induced inflammation.
In this study, we investigated the influence of CD 1 lb, P-and E-selectin on leucocyteendothelial cell adhesion in postcapillary venules of animals with indomethacin induced intestinal inflammation. While acute exposure of mesenteric venules to indomethacin by superfusion increases leucocyte adherence through a leuketriene B4 dependent mechanism27 neither leuketriene B4 nor platelet activating factor seem to contribute to the leucocyte-endothelial cell adhesion induced in our model of inflammation where indomethacin was given 48 and 24 hours before the experiment.'6 Thus, it seems probable that the pattern of adhesion molecule involvement will differ between the inflammatory responses elicited by acute (minutes) v chronic (days) treatment with indomethacin. Indeed, in a recent study by Wallace et a128 it was noted that acute exposure of the rat mesentery to indomethacin by superfusion elicited the recruitment of adherent leucocytes in postcapillary venules, a response that was attenuated by MAbs directed against either the 3-subunit (CD 18) of CD1 1/CD 18, ICAM-1 or P-selectin, but not E-selectin. These findings contrast with our findings that show no involvement of P-selectin but a significant role for E-selectin in mediating the leucocyte adherence responses in a model of indomethacin induced inflammation lasting for days. A common feature to both studies, however, is the absolute requirement for the CD 11/CD 18 adhesion glycoprotein in mediating leucocyte adherence.
The ineffectiveness of a P-selectin MAb in reducing leucocyte adherence in our model does not negate a role for this adhesion molecule in the overall inflammatory process elicited by chronic administration of indomethacin. This contention is supported by the significant reduction in indomethacin induced leucocyte emigration seen in animals pretreated with the P-selectin MAb. An explanation for the lack of effect on leucocyte adherence with a corresponding reduction in leucocyte emigration may lie in the kinetics of P-selectin expression on activated endothelial cells. Most stimuli for P-selectin mobilisation from its normal storage site in Weibel-Palade bodies have been shown to cause a transient increase in adhesion molecule expression, lasting minutes rather than hours.5 6 Consequently, at the time of observation of the mesenteric venules some two days after the initial indomethacin injection it is probable that P-selectin was no longer expressed to a significant extent on the endothelial cell surface and the adhesion molecule did not contribute to leucocyte adherence. As the P-selectin MAb may have greatly reduced leucocyte adhesion, however, in the early phase of the inflammatory response to indomethacin, then the total number of emigrated leucocytes was correspondingly reduced. This explanation is further supported by our finding that the P-selectin MAb significantly reduced the granulocyte accumulation in the intestinal mucosa that was normally seen in the indomethacin model. Tissue associated myeloperoxidase activity, a measure of granulocyte number in a tissue, should reflect the cumulative number of emigrated leucocytes. 24 In the few published studies that examine the importance of E-selectin in mediating leucocyte adherence in postcapillary venules, the endothelial cell adhesion molecule has not been very effective in preventing or reducing leucocyte recruitment. '5 28 This lack of effect of E-selectin MAbs in reducing leucocyte adhesion in some experimental models may be related to the kinetics of expression of this adhesion molecule. In response to agents such as endotoxin or interleukin 1, increased surface expressions of the molecule are seen within one to two hours with maximal expression occurring at four to six hours.7 Unlike P-selectin, which is normally stored within endothelial cells, E-selectin expression requires de novo protein synthesis.25 The effectiveness of an E-selectin MAb in our study most probably reflects an induction of adhesion molecule synthesis and increased surface expression in response to indomethacin given longterm.
Measurements of myeloperoxidase activity in the intestine of indomethacin treated animals showed that the leucocyte adhesion and emigration seen in mesenteric venules were accompanied by a significant accumulation of granulocytes in the gut mucosa. Furthermore, the ability of the different MAbs to reduce leucocyte emigration in mesenteric venules was also accompanied by an attenuated accumulation of granulocytes in the intestinal mucosa. It is important to note, however, that while the MAbs were very effective in preventing the granulocyte accumulation, no protection was afforded against the intestinal mucosal ulcerations normally elicited by this regimen of indomethacin treatment. The lack of protection against intestinal ulceration despite a blunted myeloperoxidase activity in intestinal tissue (reduced granulocyte accumulation) was already recognised in the same model of inflammation in animals rendered neutropenic17 and in animals treated with metronidazole, which inhibits the indomethacin induced leucocyte-endothelial cell adhesion (Arndt et al, unpublished results) . These findings show that granulocyte recruitment into the intestinal mucosa in this experimental model is a consequence, rather than a cause, of the mucosal lesions. The fact that MAbs diminish the gastric ulcer formation after indomethacin administration28 could result from different mechanisms of ulcer formation, which depend on feeding (intestinal ulcers) or starvation (gastric ulcers) after the indomethacin injection or the different time course of the experiments (three hours after indomethacin administration in Wallace et al128 v 48 hours in this study). Our finding that indomethacin induced ulcer formation is not influenced by circulating/emigrating granulocytes could be explained by either resident granulocytes, which are not influenced by the antibody induced reduction of granulocyte emigration or by macrophages -either resident or emigrating out of the vasculature. As the method of intravital microscopy used in both studies does not allow us to discriminate the different types of leucocytes that adhere and emigrate across the microvessels the physiological basis for the different responses in the two models of mucosal injury warrants further experimentation.
